德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

已收盘 10-15 16:08:35

2.970

+0.000

0.00%

最高3.120	最低2.905	成交量73.00万
今开3.000	昨收2.970	日振幅7.24%
总市值20.37亿	流通市值20.37亿	总股本6.86亿
成交额215.52万	换手率0.11%	流通股本6.86亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":2.97,"timestamp":1792051715009,"preClose":2.97,"halted":0,"volume":730000,"delay":0,"changeRate":0,"floatShares":686000000,"shares":686000000,"eps":-0.4455946700985624,"marketStatus":"已收盘","change":0,"latestTime":"10-15 16:08:35","open":3,"high":3.12,"low":2.905,"amount":2155245,"amplitude":0.072391,"askPrice":2.97,"askSize":500,"bidPrice":2.96,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.09861830881568209,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792114200000},"marketStatusCode":5,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":2.97,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":0.720404,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"1144897801","title":"德琪医药-B：10月15日回购13.65万股，耗资约40.41万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144897801","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144897801?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:05","pubTimestamp":1792058757,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月15日发布公告，披露当天在香港联交所场内回购普通股13.65万股，占该公司当日回购前已发行股本约0.0199%。本次回购价格介乎每股2.91港元至3.02港元，总耗资约40.41万港元。公告显示，公司于2026年6月10日通过购回授权，最多可回购67,924,413股。截至本次回购后，德琪医药-B已根据授权累计回购3,750,000股，占购回授权获通过当日已发行股本约0.5521%。同时，公司透露截至2026年10月15日的回购行为仍处于上述购回授权安排之下。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B：10月15日回购13.65万股，耗资约40.41万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675658399","title":"德琪医药-B(06996)10月15日斥资40.41万港元回购13.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675658399","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675658399?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:03","pubTimestamp":1792058636,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年10月15日，该公司斥资40.41万港元回购13.65万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1583","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184539478","title":"德琪医药-B于10月14日回购13.60万股，涉资约40.44万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184539478","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184539478?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:35","pubTimestamp":1791970548,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月14日回购普通股136,000股，占当日公司现有已发行股本的约0.0198%。本次回购的价格范围为每股港币2.905元至3.035元，合计支付金额404,436.80港元。公司现行的回购授权于2026年6月10日获股东大会通过，允许最高回购67,924,413股；截至目前已在香港联交所及其他证券交易所合计回购3,613,500股，约占该回购授权通过当日已发行股本的0.532%。公司确认已符合香港联合交易所有限公司证券上市规则及相关法例的规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B于10月14日回购13.60万股，涉资约40.44万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675310872","title":"德琪医药-B(06996)10月14日斥资40.44万港元回购13.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675310872","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675310872?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:31","pubTimestamp":1791970306,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年10月14日，该公司斥资40.44万港元回购13.6万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","BK1574","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152891650","title":"德琪医药-B回购13.7万股股份，总额约40.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152891650","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152891650?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:42","pubTimestamp":1791884552,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月13日发布翌日披露报表，宣布回购公司股份并将其作为库存股份。公司当日通过香港联交所场内回购13.7万股股份，占当日前已发行股本约0.02%，回购价格介乎每股2.905港元至3.085港元，合计支付金额约40.46万港元。回购完成后，公司已发行股本数量为685,856,632股，库存股份数量增至3,680,000股，总股本保持在689,536,632股。根据公告，德琪医药-B已于2026年6月10日获股东大会通过股份回购授权，授权总数为67,924,413股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B回购13.7万股股份，总额约40.46万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100148798","title":"德琪医药-B回购13.05万股股份，总额约40.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100148798","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100148798?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:57","pubTimestamp":1791799024,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月12日发布翌日披露报表，宣布在香港联交所场内回购股票。该公司于2026年10月12日回购合计130,500股普通股，约占相关事件前已发行股份总数的0.019%。本次回购完成后，德琪医药-B已发行股份总数为689,536,632股，其中可流通股份数为685,993,632股，库藏股数为3,543,000股。截至目前，公司已通过该授权累计回购3,340,500股，占相关购回授权获通过当日已发行股本的0.4918%。公司确认，本次股份回购交易遵守香港联交所主板上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B回购13.05万股股份，总额约40.45万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674766528","title":"德琪医药-B(06996.HK)10月12日斥资40.45万港元回购13.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674766528","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674766528?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:50","pubTimestamp":1791798624,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1574","BK1583","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176956174","title":"德琪医药-B于2026年10月9日回购25.45万股，涉资约80.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176956174","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176956174?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:42","pubTimestamp":1791538958,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月9日发布公告，披露当日通过香港联交所场内回购普通股25.45万股，占回购前公司已发行股本约0.0371%。此次回购价格区间为每股3.07港元至3.27港元，平均回购价约3.16港元，合计耗资约80.35万港元。公司回购授权于2026年6月10日获股东大会通过，授权回购股份总数为67,924,413股。截至目前，已在包括香港联交所在内的证券交易所合计回购3,210,000股，占该授权通过当日已发行股份总数的约0.4726%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B于2026年10月9日回购25.45万股，涉资约80.35万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683009","title":"德琪医药-B(06996.HK)10月9日斥资80.35万港元回购25.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674683009?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:40","pubTimestamp":1791538838,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1191","BK1583","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674300948","title":"德琪医药-B(06996)10月9日斥资80.35万港元回购25.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674300948","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674300948?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:40","pubTimestamp":1791538838,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，该公司于2026年10月9日斥资80.35万港元回购25.45万股股份，每股回购价格为3.07-3.27港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06996","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181075909","title":"德琪医药-B：10月8日回购12万股，耗资约40.36万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181075909","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181075909?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:06","pubTimestamp":1791453994,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月8日发布翌日披露报告，宣布当日通过香港联交所场内回购普通股共120,000股，占回购前公司已发行股本约0.0175%。回购价格区间每股为3.28港元至3.50港元，合计付出403,608港元。完成此次回购后，公司已发行股份数量由原先的686,498,632股减少至686,378,632股，库藏股则从3,038,000股增加至3,158,000股，总发行股本维持在689,536,632股。根据公告，德琪医药-B已于2026年6月10日获得回购授权，可回购股份总数为67,924,413股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B：10月8日回购12万股，耗资约40.36万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673944110","title":"德琪医药-B(06996.HK)10月7日斥资40.46万港元回购11.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673944110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673944110?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:13","pubTimestamp":1791368017,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","06996","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673094414","title":"德琪医药-B(06996)10月7日斥资40.46万港元回购11.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673094414","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673094414?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:13","pubTimestamp":1791368017,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年10月7日斥资40.46万港元回购11.7万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1191","BK1583","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160092355","title":"德琪医药-B：10月7日回购11.7万股，涉资约40.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160092355","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160092355?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:06","pubTimestamp":1791367585,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月7日回购11.7万股普通股，约占该公司回购活动前已发行股本的0.017%。回购价格介乎每股港币3.38元至3.50元，合计支付对价约为港币40.46万元。本次回购完成后，公司最新的已发行股本数量为686,498,632股，库藏股数量增加至3,038,000股，总股份数维持在689,536,632股。该公司此前于2026年6月10日通过回购授权，最多可回购67,924,413股。公司称，本次回购行为已符合香港联合交易所有限公司证券上市规则及相关法例的规定。公告由主席梅建明博士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B：10月7日回购11.7万股，涉资约40.46万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147260464","title":"德琪医药-B更新2026年9月股份变动月报表，本月新增9,525,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147260464","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147260464?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:45","pubTimestamp":1791362759,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月7日发布截至2026年9月30日止的证券变动月报表。报告期内，公司法定注册股本仍维持在2,000,000,000股普通股，总面值为USD 200,000，面值为每股USD 0.0001，与上月保持一致。在股权激励安排方面，2022年受限制股份单位计划本月共计透过新股发行交付10,090,000股。公司同时确认截至9月30日已符合上市规则关于公众持股量的规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166867383","title":"德琪医药-B 10月6日回购11.20万股，涉资约38.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166867383","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166867383?lang=zh_cn&edition=full","pubTime":"2026-10-06 18:06","pubTimestamp":1791281167,"startTime":"0","endTime":"0","summary":"2026年10月6日，德琪医药-B在香港联交所提交翌日披露报表。公告显示，公司于当日回购普通股112,000股，约占此前已发行股本的0.0163%。回购价格区间为每股3.395港元至3.54港元，总付出金额388,001.60港元，折合约38.80万港元。本次回购的股份将用作库藏股。公告提及，此次回购遵守香港联交所主板上市规则及相关法律规定，且未对公司此前已向香港联交所提交的说明函件作重大修改。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B 10月6日回购11.20万股，涉资约38.80万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673956701","title":"德琪医药-B(06996)10月5日斥资40.4万港元回购12.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673956701","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673956701?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:38","pubTimestamp":1791196729,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年10月5日斥资40.4万港元回购12.2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06996","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185061268","title":"德琪医药-B：10月5日回购12.20万股，耗资约40.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185061268","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185061268?lang=zh_cn&edition=full","pubTime":"2026-10-05 18:36","pubTimestamp":1791196619,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月5日公告，指该公司在香港联交所场内回购股份，回购数量为122,000股，占此次行动前已发行股本约0.0178%。本次回购的每股价格区间介乎港币3.285元至3.395元，合计耗资约404,344.60港元。本次股份购回完成后，德琪医药-B已发行股本为686,727,632股，库藏股为2,809,000股，合计股本总数维持689,536,632股。公告显示，公司于2026年6月10日通过了回购授权，授权回购股份总数为67,924,413股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B：10月5日回购12.20万股，耗资约40.43万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673771528","title":"部分医药股早盘高开 德琪医药-B涨超5%康希诺生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673771528","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673771528?lang=zh_cn&edition=full","pubTime":"2026-10-05 09:34","pubTimestamp":1791164040,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端部分医药股早盘高开，截至发稿，德琪医药-B（06996）上涨5.26%，报3.5港元；康希诺生物（06185）上涨3.58%，报35.88港元；昭衍新药（06127）上涨3.22%，报31.4港元；金斯瑞生物科技（01548）上涨2.93%，报45港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-05/doc-iniucpwr6623848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1191","BK1515","BK1583","BK1574","09939","06996","06185","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191394205","title":"德琪医药-B回购9.3万股股份，耗资约30.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191394205","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191394205?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:31","pubTimestamp":1790937116,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月2日发布公告，披露当日于香港联交所进行股份回购的具体信息。本次回购股份数量为93,000股，约占公司本次回购前已发行股份的0.0135%，每股回购价介乎3.215港元至3.325港元，合共耗资约30.46万港元。截至目前，德琪医药-B已合计回购2,484,500股，占购回授权通过当日已发行股份数目的0.3658%。此外，本次回购后，公司进行任何新的股本发行或出售、转让库存股份的暂止期截至2026年11月1日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B回购9.3万股股份，耗资约30.46万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.1514},{"period":"1month","weight":-0.1328},{"period":"3month","weight":-0.325},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.462},{"period":"ytd","weight":-0.2164}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.088806},{"month":2,"riseRate":0.166667,"avgChangeRate":0.291534},{"month":3,"riseRate":0.5,"avgChangeRate":0.091928},{"month":4,"riseRate":0.5,"avgChangeRate":-0.034689},{"month":5,"riseRate":0.5,"avgChangeRate":0.014763},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.127204},{"month":7,"riseRate":0.333333,"avgChangeRate":0.018605},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.036567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.026777},{"month":10,"riseRate":0.333333,"avgChangeRate":0.003749},{"month":11,"riseRate":0.6,"avgChangeRate":0.05603},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.002542}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}